Emergent BioSolutions (United States)
- Research works
- 106 ▲ 96% vs 2013–17
- Citations
- 2.4k 22.4 per fractional work
- Top-10% rate
- 10.5% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: Emergent BioSolutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.7×. Every wedge is a field page.
- Immunology and Microbiology 13.7×
- Medicine 3.0×
- Pharmacology, Toxicology and Pharmaceutics 2.6×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Veterinary 2.3×
- Chemistry 1.3×
- Nursing 0.9×
- Earth and Planetary Sciences 0.6×
- Agricultural and Biological Sciences 0.6×
- Neuroscience 0.5×
- Materials Science 0.4×
- Environmental Science 0.3×
- Health Professions 0.3×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Mathematics 0.0×
- Arts and Humanities 0.0×
- Computer Science 0.0×
Which keywords describe research at Emergent BioSolutions (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine, Substance Use Disorders, Chronic Pain Management, Opioid Prescribing, Immune Response and Pandemic.
- Viral Diseases
- Tularemia
- Anthrax
- Viral Hemorrhagic Fevers
- Cancer Immunotherapy
- Probiotics
- H1N1
- Zika Virus
- Antibodies
- antibody
- Ebola Virus
- Virus
- Coronavirus
- Viral Transmission
- Innate Immunity
- Immunity
- Pandemic
- Opioid Prescribing
- Substance Use Disorders
- Pathogenesis
- Epidemiology
- Vaccine
- Chronic Pain Management
- Immune Response
- Vaccine Development
- Public Health
- SARS-CoV-2
- Antigen Presentation
- Genomics
- ACE2 Receptor
- Outbreak
- spike protein
- Arboviral Diseases
- Gut Microbiota
- Influenza
- Genomic Analysis
- Genetic Diversity
- Zoonotic Infections
- Antibiotic Resistance
- Dendritic Cells
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 5.5×18 topics
- Pathogenesis6▲ 34×6 topics
- Vaccine5▲ 35×8 topics
- Substance Use Disorders5▲ 189×2 topics
- Chronic Pain Management5▲ 411×1 topic
- Opioid Prescribing5▲ 411×1 topic
- Immune Response4▲ 18×8 topics
- Pandemic3▲ 8.5×3 topics
- Vaccine Development3▲ 30×4 topics
- Immunity3▲ 18×2 topics
- Public Health3▲ 5.2×6 topics
- Innate Immunity2▲ 22×4 topics
- SARS-CoV-22▲ 19×4 topics
- Viral Transmission2▲ 38×2 topics
- Antigen Presentation2▲ 60×2 topics
- Coronavirus2▲ 25×2 topics
- Genomics2▲ 18×2 topics
- Virus2▲ 55×2 topics
- ACE2 Receptor2▲ 21×2 topics
- Ebola Virus2▲ 190×1 topic
- Outbreak2▲ 142×1 topic
- antibody2▲ 42×1 topic
- spike protein2▲ 42×1 topic
- Antibodies2▲ 76×2 topics
- Arboviral Diseases2▲ 65×1 topic
- Zika Virus2▲ 65×1 topic
- Gut Microbiota1▲ 11×4 topics
- H1N11▲ 130×1 topic
- Influenza1▲ 96×1 topic
- Probiotics1▲ 17×4 topics
- Genomic Analysis1▲ 14×2 topics
- Cancer Immunotherapy1▲ 22×2 topics
- Genetic Diversity1▲ 7.7×2 topics
- Viral Hemorrhagic Fevers1▲ 71×1 topic
- Zoonotic Infections1▲ 57×1 topic
- Anthrax1▲ 174×1 topic
- Antibiotic Resistance1▲ 7.8×2 topics
- Tularemia1▲ 174×1 topic
- Dendritic Cells1▲ 32×1 topic
- Viral Diseases1▲ 44×2 topics
Which research topics does Emergent BioSolutions (United States) publish most on?
By volume in 2022–2025: Opioid Use Disorder Treatment, Viral Infections and Outbreaks Research, SARS-CoV-2 and COVID-19 Research and Mosquito-borne diseases and control.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 5 works
- 2 Viral Infections and Outbreaks Research Infectious Diseases 2 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 4 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 2 works
- 5 Influenza Virus Research Studies Epidemiology 1 works
- 6 Viral Infections and Vectors Infectious Diseases 1 works
- 7 Bacillus and Francisella bacterial research Molecular Biology 1 works
- 8 Immunotherapy and Immune Responses Immunology 1 works
- 9 Vaccine Coverage and Hesitancy Health 1 works
- 10 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Emergent BioSolutions (United States)'s research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- NIST Center for Neutron Research
- Material Measurement Laboratory
- Center for Nanoscale Science and Technology
- Information Technology Laboratory
- Robotic Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.